File Download
Supplementary

Conference Paper: Polypoidal Choroidal Vasculopathy - all you need to know!

TitlePolypoidal Choroidal Vasculopathy - all you need to know!
Authors
Issue Date2012
PublisherWOC2012.
Citation
The World Ophthalmology Congress 2012 (WOC2012), Abu Dhabi, United Arab Emirates, 16-20 February 2012. In Scientific Program of WOC2012, 2012, p. 116 How to Cite?
AbstractOBJECTIVES: To highlight the clinical features, diagnostic criteria, treatment strategies, and future developments in polypoidal choroidal vasculopathy (PCV). SUMMARY OF CONTENT: PCV is characterized by recurrent subretinal pigment epithelial hemorrhages. Before indocyanine-green angiography (ICG) imaging was popular, PCV was sometimes misdiagnosed as neovascular age-related macular degeneration (AMD). With the advent of imaging modalities and deeper understandings of the disease, PCV is now recognized as a separate entity, with its own unique profile of clinical manifestations. Treatment strategy towards PCV has been revolutionized by recent clinical trials using combination therapy with ranibizumab and verteporfin. Currently, significant differences exist between treatment for PCV and neovascular AMD. There is a clear need in distinguishing PCV from neovascular AMD. Clinical photos, ICG findings, and optical coherence tomography scans will be used to illustrate real cases. Small quiz towards end of course will help audience fortify knowledge acquired. At the conclusion of this course, the audience will be able to distinguish a case of PCV, from a case of neovascular AMD. They will know how to formulate treatment strategies for a new case of PCV, and the most up-to-date evidences involved.
DescriptionCO-RET-MO 415
Persistent Identifierhttp://hdl.handle.net/10722/166819

 

DC FieldValueLanguage
dc.contributor.authorWong, Ien_US
dc.contributor.authorLai, Wen_US
dc.contributor.authorWong, D-
dc.date.accessioned2012-09-20T08:50:22Z-
dc.date.available2012-09-20T08:50:22Z-
dc.date.issued2012en_US
dc.identifier.citationThe World Ophthalmology Congress 2012 (WOC2012), Abu Dhabi, United Arab Emirates, 16-20 February 2012. In Scientific Program of WOC2012, 2012, p. 116en_US
dc.identifier.urihttp://hdl.handle.net/10722/166819-
dc.descriptionCO-RET-MO 415-
dc.description.abstractOBJECTIVES: To highlight the clinical features, diagnostic criteria, treatment strategies, and future developments in polypoidal choroidal vasculopathy (PCV). SUMMARY OF CONTENT: PCV is characterized by recurrent subretinal pigment epithelial hemorrhages. Before indocyanine-green angiography (ICG) imaging was popular, PCV was sometimes misdiagnosed as neovascular age-related macular degeneration (AMD). With the advent of imaging modalities and deeper understandings of the disease, PCV is now recognized as a separate entity, with its own unique profile of clinical manifestations. Treatment strategy towards PCV has been revolutionized by recent clinical trials using combination therapy with ranibizumab and verteporfin. Currently, significant differences exist between treatment for PCV and neovascular AMD. There is a clear need in distinguishing PCV from neovascular AMD. Clinical photos, ICG findings, and optical coherence tomography scans will be used to illustrate real cases. Small quiz towards end of course will help audience fortify knowledge acquired. At the conclusion of this course, the audience will be able to distinguish a case of PCV, from a case of neovascular AMD. They will know how to formulate treatment strategies for a new case of PCV, and the most up-to-date evidences involved.-
dc.languageengen_US
dc.publisherWOC2012.-
dc.relation.ispartofScientific Program of WOC2012en_US
dc.titlePolypoidal Choroidal Vasculopathy - all you need to know!en_US
dc.typeConference_Paperen_US
dc.identifier.emailWong, I: wongyhi@hku.hken_US
dc.identifier.emailLai, W: wicolai@hku.hken_US
dc.identifier.emailWong, D: shdwong@hku.hk-
dc.identifier.authorityWong, I=rp01467en_US
dc.description.naturelink_to_OA_fulltext-
dc.identifier.hkuros207468en_US
dc.identifier.spage116-
dc.identifier.epage116-
dc.publisher.placeUnited Arab Emirates-
dc.description.otherThe World Ophthalmology Congress 2012 (WOC2012), Abu Dhabi, United Arab Emirates, 16-20 February 2012. In Scientific Program of WOC2012, 2012, p. 116-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats